All opinions contained within pieces presented on this page are published at the discretion of the author and/or publisher. The DETOUR System is an investigational device limited by United States law to investigational use. The DETOUR System is not available for sale.
PQ Bypass Announces Unconditional IDE Approval From U.S. FDA to Start TORUS SFA Stent Graft Pivotal Study (TORUS-2)
10/08/2019
PQ Bypass Announces Appointment of Stanton J. Rowe to Board of Directors
1/22/2019
PQ Bypass Receives $60M in Equity Financing
1/8/2019
PQ Bypass Announces $60 Million Financing to Advance New Therapeutic Approach to Peripheral Arterial Disease
1/8/2019
PQ Bypass raises $60m
1/8/2019
Healio: DETOUR I: 18-month Results Encouraging For Percutaneous Bypass System
11/9/2018
VIVA Physicians: Groundbreaking Endovascular Clinical Trial Results Announced At VIVA 18
11/6/2018
Healio: DETOUR I- Percutaneous Bypass Procedure Successful at 12 Months
7/1/2018
Endovascular Today: Twelve-Month Data Presented for PQ Bypass' Detour System
6/28/2018
Mass Device: PQ Bypass Touts 1-year Detour Study Data
6/28/2018
PQ Bypass: PQ Bypass Reports Positive 12-Month Results for Entirely New Procedure to Treat Extremely Long SFA Lesions in Patients with PAD
6/28/2018
PQ Bypass: PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries
2/22/2018
Endovascular Today: PQ Bypass Receives IDE to Initiate DETOUR II Pivotal Trial
12/13/2017
PQ Bypass: PQ Bypass Reports Positive Results for the Novel DETOUR System in Patients With Tough to Treat Long Blockages in the Femoropopliteal Artery
9/12/2017
Mass Device: PQ Bypass Touts Subset Analysis Data from DETOUR System Trial
9/12/2017
PQ Bypass: PQ Bypass to Unveil New Data From DETOUR I at VIVA 17
9/8/2017
Frost & Sullivan: PQ Bypass- Recipient of Frost & Sullivan's 2017 European Peripheral Artery Disease Interventions Technology Innovation Award
8/31/2017
Frost & Sullivan: PQ Bypass Earns Frost & Sullivan's European Technology Innovation Award for Its Proprietary DETOUR System for Percutaneous Bypass
8/31/2017
Cision: PQ Bypass Earns Frost & Sullivan's European Technology Innovation Award
8/31/2017
Cision: Sanarus Technologies Appoints Senior Medtech Executive Heather Simonsen to Board of Directors
4/24/2017
Vascular News: PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies
3/14/2017
Medical Design Technology: PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies
3/14/2017
Medical Device Network: PQ Bypass's DETOUR Percutaneous Technologies Secure CE mark
3/14/2017
FierceBiotech: PQ Bypass Gets CE Mark for Peripheral Artery Disease Tech
3/13/2017
Mass Device: PQ Bypass Wins CE Mark for Trio of PAD Tools
3/13/2017
Endovascular Today: CE Mark Granted for PQ Bypass' Detour Percutaneous Bypass Technologies
3/13/2017
PQ Bypass: PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies
3/13/2017
TCTMD: Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study
2/10/2017
PQ Bypass: PQ Bypass Announces Positive Results From DETOUR I Study at LINC 2017
1/24/2017
PQ Bypass: PQ Bypass Announces Schedule of Presentations at LINC 2017
1/19/2017
Mass Device Today: Personnel Moves Sept. 15, 2016
9/15/2017
Endovascular Today: Early Findings Presented for PQ Bypass’ Endovascular Femoropopliteal Artery Bypass Procedure
9/14/2016